Trial · NCT00098293
Participant flow65
How many started, completed or left each group, period by period.
1 to 20 of 65
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind (DB) Phase | STARTED | Maraviroc Once Daily + CBV (DB) | 177 | |
| Double-blind (DB) Phase | STARTED | Maraviroc Twice Daily + CBV (DB and OL) | 368 | |
| Double-blind (DB) Phase | STARTED | Efavirenz Once Daily + CBV (DB and OL) | 372 | |
| Double-blind (DB) Phase | STARTED | Maraviroc Twice Daily + CBV (OL) | 0 | |
| Double-blind (DB) Phase | STARTED | Maraviroc Twice Daily + CBV (SP) | 0 | |
| Double-blind (DB) Phase | Treated | Maraviroc Once Daily + CBV (DB) | 174 | |
| Double-blind (DB) Phase | Treated | Maraviroc Twice Daily + CBV (DB and OL) | 360 | |
| Double-blind (DB) Phase | Treated | Efavirenz Once Daily + CBV (DB and OL) | 361 | |
| Double-blind (DB) Phase | Treated | Maraviroc Twice Daily + CBV (OL) | 0 | |
| Double-blind (DB) Phase | Treated | Maraviroc Twice Daily + CBV (SP) | 0 | |
| Double-blind (DB) Phase | COMPLETED | Maraviroc Once Daily + CBV (DB) | 0 | |
| Double-blind (DB) Phase | COMPLETED | Maraviroc Twice Daily + CBV (DB and OL) | 202 | |
| Double-blind (DB) Phase | COMPLETED | Efavirenz Once Daily + CBV (DB and OL) | 202 | |
| Double-blind (DB) Phase | COMPLETED | Maraviroc Twice Daily + CBV (OL) | 0 | |
| Double-blind (DB) Phase | COMPLETED | Maraviroc Twice Daily + CBV (SP) | 0 | |
| Double-blind (DB) Phase | NOT COMPLETED | Maraviroc Once Daily + CBV (DB) | 177 | |
| Double-blind (DB) Phase | NOT COMPLETED | Maraviroc Twice Daily + CBV (DB and OL) | 166 | |
| Double-blind (DB) Phase | NOT COMPLETED | Efavirenz Once Daily + CBV (DB and OL) | 170 | |
| Double-blind (DB) Phase | NOT COMPLETED | Maraviroc Twice Daily + CBV (OL) | 0 | |
| Double-blind (DB) Phase | NOT COMPLETED | Maraviroc Twice Daily + CBV (SP) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00098293/flow